Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus

American Journal of the Medical Sciences

Volumn 312, Issue 3, 1996, Pages 118-122

  Keiser, Philip ^a   Higgs, Elizabeth ^b   Smith, James ^b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

AIDS; bacteremia; HIV; neutropenia; trimethoprim sulfamethoxazole

Indexed keywords

SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUTROPENIA; RISK FACTOR;

EID: 0029824660     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)41775-6     Document Type: Article

References (21)

1. Gilks CF, Brindle RJ, Otieno LS, Simani PM, Newnham RS, Bhatt SH, et al. Life threatening bacteremia in HIV-1 seropositive adults admitted to a hospital in Nairobi, Kenya. Lancet. 1990:336:545-549.
2. Krumholz HM, Sande MA, Lo B. Community acquired bacteremia in patients with AIDS: Clinical presentation, bacteriology, and outcome. Am J Med. 1989;86:776-779.
3. Schrager L, Klein RS, Freeman K, et al. Analysis of bacteremia in patients with AIDS. Abstract MP155. Presented at the IIIrd International Conference on AIDS; June 1-5, 1987; Washington D.C.
4. Rolson KV, Radentz S, Rodrigues S. Bacterial and fungal infections in patients with the acquired immunodeficiency syndrome. Cancer Detect Prev. 1990;14:377.
5. Fitchenbaum C, Woeltje KF, Powderly W. Serious Pseudomonas aeruginosa infections in patients infected with HIV: A case-control study. Clin Infect Dis. 1995;3:417-22.
6. Matz K, Emmerling P, Loch O, et al. Bacteremia in HIV infected patients with ARC and AIDS. In: Abstracts of 9th International AIDS Conference, Berlin, Germany, June 6-11, 1993; International Aids Society.
7. Fitchenbaum C, Dunagan WC, Powderly W. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: A case control study of risk factors and outcome. J Acquir Immune Defic Syndr. 1995;8:51-57.
8. Farber BF, Lesser M, Kaplan MH, Wottman J, Napolitano B, Armellino D. Clinical significance of neutropenia in patients with the human immunodeficiency virus. Infect Control Hosp Epidemiol. 1991;12:429-434.
9. Northfelt, Hanblet J, Aragon T, et al. Outcome of febrile neutropenia in patients with AIDS related non-Hodgkin's lymphoma. Blood. 1990;76(suppl 1)491.
10. Shamak S, Bartlet JA. Zidovudine-induced neutropenia: Are we too cautious? Lancet. 1989;1:91-92.
11. Moore RD, Kerulye JC, Chaision RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med. 1995;155:1965-70.
12. Hardy WD, Freiberg J, Finkelstein DM, et. al. A controlled trial trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 012. N Engl J Med. 1992;327: 1842-48.
13. EORTC International Antimicrobial Therapy Project Group. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. J Infect Dis. 1984;150:372-379.
14. Ward TT, Thomas RG, Fye R, et al. Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: Evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affair cooperative study. Clin Infect Dis. 1993;17:323-31.
15. Bow EJ, Ronald A. Antibacterial chemoprophylaxis in neutropenic patients - where do we go from here? Clin Infect Dis. 1993;17:333-37.
16. Trillet-Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer. 1993;29: 319-24.
17. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Med. 1991;315:164-70.
18. Kimura S, Matsuda J, Ikematsu S, Miyazono K, Ito A, Nakamata T, et al. Efficacy of rG-CSF on neutropenia in patient with AIDS. AIDS. 1990;4:1251-1255.
19. van der Wouw PA, van Leeuwen R, van Oers RHJ, Lange JMA, Danner SA. Effects of rG-CSF on leukopenia in zidovudine treated patients with AIDS and AIDS related complex, a phase I/II trial. Br J Haematol. 1991;78:319-24.
20. Jacobson MA, Donnell JJ, Porteous D, Brodie HR, Feigal D, Mills J. Retinal and gastrointestinal disease due to CMV in patients with AIDS; prevalence, natural history and response to ganciclovir therapy. Q J Med. 1988;254:473-486.
21. Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Allon NK, Souza L, et al. Combined therapy with recombinant G-CSF and erythropoietin decreases hematologic toxicity from zidovudine. Blood. 1991;77:2109-17.